Nagavendra Kommineni

5.6k total citations · 4 hit papers
53 papers, 4.1k citations indexed

About

Nagavendra Kommineni is a scholar working on Molecular Biology, Biomaterials and Pharmaceutical Science. According to data from OpenAlex, Nagavendra Kommineni has authored 53 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 14 papers in Biomaterials and 10 papers in Pharmaceutical Science. Recurrent topics in Nagavendra Kommineni's work include RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (11 papers) and Nanoplatforms for cancer theranostics (6 papers). Nagavendra Kommineni is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Nanoparticle-Based Drug Delivery (11 papers) and Nanoplatforms for cancer theranostics (6 papers). Nagavendra Kommineni collaborates with scholars based in India, United States and Israel. Nagavendra Kommineni's co-authors include Wahid Khan, Upendra Bulbake, Sindhu Doppalapudi, Arun Butreddy, Raviteja Bulusu, Narendar Dudhipala, Sagar Salave, Mandip Singh, Derajram Benival and Dhwani Rana and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and International Journal of Molecular Sciences.

In The Last Decade

Nagavendra Kommineni

52 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liposomal Formulations in Clinical Use: An Updated Review

2017 1.5k citations Nagavendra Kommineni, Wahid Khan et al. Pharmaceutics profile →
Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications

2023 312 citations Nimeet Desai, Dhwani Rana et al. Pharmaceutics profile →
Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products

2020 280 citations Raviteja Bulusu, Nagavendra Kommineni et al. International Journal of Pharmaceutics profile →
A Comprehensive Review of mRNA Vaccines

2023 233 citations Vrinda Gote, Pradeep Kumar Bolla et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nagavendra Kommineni India	26	1.7k	1.4k	1.0k	936	436	53	4.1k
Amr S. Abu Lila Egypt	36	2.1k 1.2×	1.5k 1.1×	922 0.9×	701 0.7×	532 1.2×	143	4.3k
Tuan Hiep Tran South Korea	34	1.2k 0.7×	1.2k 0.9×	1.1k 1.1×	864 0.9×	316 0.7×	91	3.4k
Aude Le Breton Belgium	3	1.4k 0.8×	1.6k 1.2×	1.2k 1.2×	792 0.8×	365 0.8×	3	3.8k
Christian Celia Italy	47	2.2k 1.3×	1.8k 1.3×	1.2k 1.2×	1.6k 1.7×	358 0.8×	119	5.6k
Lifang Yin China	38	1.6k 0.9×	1.6k 1.2×	1.1k 1.0×	1.2k 1.2×	266 0.6×	120	4.6k
Eduardo Ansorena Spain	17	1.1k 0.6×	1.4k 1.0×	987 1.0×	854 0.9×	369 0.8×	30	3.7k
Donato Cosco Italy	43	1.8k 1.0×	1.8k 1.3×	1.2k 1.2×	1.3k 1.4×	230 0.5×	115	5.1k
Vijay Mishra India	37	1.5k 0.9×	1.0k 0.7×	1.0k 1.0×	1.1k 1.1×	278 0.6×	164	4.9k
Joana M. Silva Portugal	28	1.3k 0.8×	1.9k 1.4×	1.5k 1.4×	911 1.0×	647 1.5×	38	5.2k
María J. Blanco‐Prieto Spain	45	1.8k 1.0×	1.8k 1.3×	1.4k 1.4×	1.2k 1.3×	223 0.5×	146	5.7k

Countries citing papers authored by Nagavendra Kommineni

Since Specialization

Citations

This map shows the geographic impact of Nagavendra Kommineni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagavendra Kommineni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagavendra Kommineni more than expected).

Fields of papers citing papers by Nagavendra Kommineni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagavendra Kommineni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagavendra Kommineni. The network helps show where Nagavendra Kommineni may publish in the future.

Co-authorship network of co-authors of Nagavendra Kommineni

This figure shows the co-authorship network connecting the top 25 collaborators of Nagavendra Kommineni. A scholar is included among the top collaborators of Nagavendra Kommineni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagavendra Kommineni. Nagavendra Kommineni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jyothi, Vaskuri G. S. Sainaga, Mehmet R. Dokmeci, Menekşe Ermis, et al.. (2025). Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery. Biomolecules. 15(6). 802–802. 8 indexed citations

Jyothi, Vaskuri G. S. Sainaga & Nagavendra Kommineni. (2024). Peptide Conjugated Boron Neutron Capture Therapy for Enhanced Tumor Targeting. Nanotheranostics. 8(4). 458–472. 8 indexed citations

Prasad, Rajendra, Vaskuri G. S. Sainaga Jyothi, Nagavendra Kommineni, et al.. (2024). Biomimetic Ghost Nanomedicine-Based Optotheranostics for Cancer. Nano Letters. 24(27). 8217–8231. 12 indexed citations

Desai, Nimeet, et al.. (2024). Nanofibrous Microspheres: A Biomimetic Platform for Bone Tissue Regeneration. ACS Applied Bio Materials. 7(7). 4270–4292. 5 indexed citations

Gote, Vrinda, Pradeep Kumar Bolla, Nagavendra Kommineni, et al.. (2023). A Comprehensive Review of mRNA Vaccines. International Journal of Molecular Sciences. 24(3). 2700–2700. 233 indexed citations breakdown →

Salave, Sagar, Dhwani Rana, Bichismita Sahu, et al.. (2023). Peptide Engraftment on PEGylated Nanoliposomes for Bone Specific Delivery of PTH (1-34) in Osteoporosis. Pharmaceutics. 15(2). 608–608. 17 indexed citations

Desai, Nimeet, Dhwani Rana, Sagar Salave, et al.. (2023). Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications. Pharmaceutics. 15(4). 1313–1313. 312 indexed citations breakdown →

Kommineni, Nagavendra, João Conde, Sedef Tamburacı, et al.. (2023). Engineered Liposomes in Interventional Theranostics of Solid Tumors. ACS Biomaterials Science & Engineering. 9(8). 4527–4557. 34 indexed citations

Karunakaran, Bharathi, Raghav Gupta, Pranav Patel, et al.. (2023). Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications. Vaccines. 11(3). 661–661. 39 indexed citations

10.

Desai, Nimeet, Dhwani Rana, Sagar Salave, et al.. (2023). “Bioinspired” Membrane-Coated Nanosystems in Cancer Theranostics: A Comprehensive Review. Pharmaceutics. 15(6). 1677–1677. 25 indexed citations

11.

Damiri, Fouad, Sagar Salave, Yahya Bachra, et al.. (2023). Properties and valuable applications of superabsorbent polymers: a comprehensive review. Polymer Bulletin. 81(8). 6671–6701. 19 indexed citations

12.

Corrie, Leander, Ankit Awasthi, Jaskiran Kaur, et al.. (2023). Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies. Pharmaceuticals. 16(2). 197–197. 35 indexed citations

13.

Corrie, Leander, et al.. (2023). HPMCAS-Based Amorphous Solid Dispersions in Clinic: A Review on Manufacturing Techniques (Hot Melt Extrusion and Spray Drying), Marketed Products and Patents. Materials. 16(20). 6616–6616. 8 indexed citations

14.

Jyothi, Vaskuri G. S. Sainaga, et al.. (2022). Stability characterization for pharmaceutical liposome product development with focus on regulatory considerations: An update. International Journal of Pharmaceutics. 624. 122022–122022. 106 indexed citations

15.

Patel, Nilkumar, Nagavendra Kommineni, Sunil Kumar Surapaneni, et al.. (2021). Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models. International Journal of Pharmaceutics. 607. 120943–120943. 47 indexed citations

16.

Bulusu, Raviteja, et al.. (2020). Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. International Journal of Pharmaceutics. 586. 119560–119560. 280 indexed citations breakdown →

17.

Saka, Raju, Harsha Jain, Nagavendra Kommineni, Naveen Chella, & Wahid Khan. (2020). Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice. Journal of Drug Delivery Science and Technology. 58. 101691–101691. 47 indexed citations

18.

Kommineni, Nagavendra, Shaheen Mahira, Abraham J. Domb, & Wahid Khan. (2019). Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects. Pharmaceutics. 11(3). 141–141. 47 indexed citations

19.

Mahira, Shaheen, Nagavendra Kommineni, Gulam Mohammed Husain, & Wahid Khan. (2018). Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomedicine & Pharmacotherapy. 110. 803–817. 86 indexed citations

20.

Muntimadugu, Eameema, Nagavendra Kommineni, & Wahid Khan. (2017). Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy. Pharmacological Research. 126. 109–122. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact